Sperling Prostate Center

Artificial Intelligence in Medicine: How AI Can Identify When to Add ADT to Prostate Cancer Radiation

Artificial Intelligence in Medicine
Aggressive prostate cancer (PCa) comes with higher chances for recurrence—and often there’s no way to know if the PCa has started to spread at the time of treatment. It’s like a time bomb with an unanswered question: has the clock been activated? Therefore, today’s clinical standard of care treats it as if the clock is keep reading

Artificial Intelligence in Medicine: Competition Improves AI’s Accuracy in Grading Prostate Cancer

How to Use a Medical “Group Mind” to Train Artificial Intelligence
According to Swedish and Dutch experts, there’s often a bias problem in Artificial Intelligence (AI) programs designed to grade prostate cancer (PCa) aggressiveness. That is, those who develop algorithms that are trained on a particular set of data are also the people who evaluate their accuracy. Where’s the objectivity in that method? There’s a risk keep reading
WordPress Image Lightbox